4.6 Review

Organoids as a Model for Precision Medicine in Malignant Pleural Mesothelioma: Where Are We Today?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

New Era for Malignant Pleural Mesothelioma: Updates on Therapeutic Options

Anne S. Tsao et al.

Summary: Malignant pleural mesothelioma (MPM) is a rare malignancy with limited treatment options. Recent advances have led to changes in treatment standards, including the use of a novel biomedical device in combination with platinum-pemetrexed and the inclusion of immunotherapy as a frontline treatment option. Proper identification of the MPM histology is crucial in determining the optimal treatment plan. Immunotherapy can benefit all MPM patients and should be considered at some point during treatment. Ongoing research is focusing on defining frontline therapy in the unresectable setting and addressing immunotherapy refractory cases.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Review Chemistry, Physical

Next-generation cancer organoids

Bauer L. LeSavage et al.

Summary: The translation discusses how organotypic models of patient-specific tumors are changing our understanding of cancer heterogeneity and personalized medicine. These models can preserve genetic, proteomic, morphological, and pharmacotypic features of the parent tumor in vitro, and offer genomic and environmental manipulation. However, current cancer organoid culture techniques are uncontrolled and irreproducible, hindering the acceleration of insights into patient care.

NATURE MATERIALS (2022)

Article Oncology

A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology

Katrin P. Guillen et al.

Summary: Models that recapitulate the complexity of human tumors are urgently needed to develop more effective cancer therapies. In this study, researchers report a bank of human patient-derived xenografts and organoid cultures from breast cancers that are resistant to treatment and have metastasized. They demonstrate the feasibility and cost-effectiveness of using these models for drug screening, and also show the potential of applying precision oncology in real-time clinical care. The study provides valuable methods and resources for functional precision medicine and drug development for human breast cancer.

NATURE CANCER (2022)

Article Gastroenterology & Hepatology

Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance

Jiaye Liu et al.

Summary: The study successfully established murine and human 3D co-culture models and demonstrated robust effects of cancer-associated fibroblasts (CAFs) in nurturing liver cancer and promoting treatment resistance.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Cell Biology

Opportunities and challenges of glioma organoids

Xiangdong Xu et al.

Summary: Glioma, the most common primary brain tumor with poor prognosis, requires an urgent platform to study its cell dynamics and develop effective treatments. Organoids, a 3D structure similar to human tissues, are considered the most suitable research platform for glioma research, overcoming the drawbacks of previous models and contributing to the diagnosis and treatment of glioma.

CELL COMMUNICATION AND SIGNALING (2021)

Article Medicine, General & Internal

First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial

Paul Baas et al.

Summary: Nivolumab plus ipilimumab demonstrated significant improvement in overall survival compared to standard chemotherapy for unresectable malignant pleural mesothelioma. This first-in-class treatment regimen has been approved for previously untreated patients in the USA and showed promising outcomes with manageable adverse events.

LANCET (2021)

Review Chemistry, Physical

Rethinking organoid technology through bioengineering

Elena Garreta et al.

Summary: Significant progress has been made in the differentiation of human pluripotent stem cells and the development of organoids. The convergence of stem cell biology and bioengineering allows for controlled stimuli to be provided to the system. Engineering solutions are emphasized to control the self-organization and functionality of stem cell-derived organoids.

NATURE MATERIALS (2021)

Article Oncology

A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation

Yuan-Hung Lo et al.

Summary: Mutations in ARID1A are common in human cancer, but the oncogenic consequences of these mutations remain unclear. Using CRISPR/Cas9, researchers induced dysplasia, tumorigenicity, and mucinous differentiation in human gastric organoids, providing insights into the pathways affected by ARID1A mutation. Further analysis showed vulnerability of ARID1A-deficient organoids to inhibition of BIRC5/survivin, highlighting this pathway as crucial for early-stage gastric tumorigenesis.

CANCER DISCOVERY (2021)

Article Oncology

Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma

Kathrin Oehl et al.

Summary: In patients with malignant pleural mesothelioma (MPM), mutations or deletions of BAP1 were found to predict resistance to chemotherapy, serving as a potential companion biomarker for treatment decision. This study highlights the importance of genetic markers in predicting treatment response in MPM patients.

CLINICAL CANCER RESEARCH (2021)

Review Respiratory System

Use of preclinical models for malignant pleural mesothelioma

Marie Shamseddin et al.

Summary: Malignant pleural mesothelioma is an aggressive cancer with a median survival of 12-18 months and existing models have limitations, so new technologies are being developed to study effective treatments.

THORAX (2021)

Article Multidisciplinary Sciences

Patient-derived xenografts and organoids model therapy response in prostate cancer

Sofia Karkampouna et al.

Summary: Therapy resistance and metastatic processes in prostate cancer remain a challenge, but a new patient-derived xenograft model and organoid system may offer a personalized approach to treatment. This study reveals potential new strategies for screening drug responses and targeting advanced cases with acquired resistance to standard therapies.

NATURE COMMUNICATIONS (2021)

Article Oncology

Non-matrigel scaffolds for organoid cultures

Savneet Kaur et al.

Summary: Organoids are 3D cell cultures derived from tissue-resident or embryonic stem cells on hydrogels with defined growth factors. Matrigel is commonly used, but other natural and synthetic hydrogel scaffolds are being explored due to its limitations. Developing customized hydrogels for organoid cultures is crucial for various therapeutic and pharmaceutical applications.

CANCER LETTERS (2021)

Article Oncology

3D human liver organoids: An in vitro platform to investigate HBV infection, replication and liver tumorigenesis

Shringar Rao et al.

Summary: Hepatitis B Virus (HBV) infection is a major cause of chronic liver cirrhosis and hepatocellular carcinoma (HCC) worldwide, and organoid technology has emerged as a powerful tool for studying this disease.

CANCER LETTERS (2021)

Review Oncology

Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy

Jingjing Qu et al.

Summary: Patient-derived cancer organoids have overcome the limitations of traditional models, closely mimicking the pathophysiological features of natural tumorigenesis and metastasis, enabling personalized treatment and biomarker discovery. Combining cancer organoids with other technologies and treatments has proven effective in overcoming limitations and developing more suitable model systems.

CANCER COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Lung cancer organoids analyzed on microwell arrays predict drug responses of patients within a week

Yawei Hu et al.

Summary: The time-consuming nature of establishing patient-derived organoids (PDOs) hinders their implementation in clinic-based drug sensitivity tests, but a microwell array-based method was shown by the authors to predict patient responses to anti-cancer therapies within a week using lung cancer organoids.

NATURE COMMUNICATIONS (2021)

Article Oncology

Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation

Rachelle Asciak et al.

Summary: This study found that pleural fluid alone is sufficient for cancer cell proliferation in vitro, regardless of the source of the pleural fluid. These results support the hypothesis that pleural fluid has important pro-growth biological properties, but the mechanisms for this effect are unclear and likely not specific to malignant effusion.

FRONTIERS IN ONCOLOGY (2021)

Review Medicine, General & Internal

Perspectives on the Treatment of Malignant Pleural Mesothelioma

Sam M. Janes et al.

Summary: Mesothelioma, mostly caused by asbestos exposure, has a decreasing incidence but high mortality due to late diagnosis and treatment resistance. Pemetrexed-cisplatin and immune checkpoint inhibitors have shown modest survival extension.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Genetics & Heredity

Multi-site tumor sampling highlights molecular intra-tumor heterogeneity in malignant pleural mesothelioma

Clement Meiller et al.

Summary: This study investigated intra-tumor heterogeneity in malignant pleural mesothelioma (MPM) using the largest series to date and multi-omics profiling of a substantial series of multi-site tumor samples. The results revealed patient-dependent spatial heterogeneity at genetic, transcriptomic, and epigenetic levels, as well as changes in the immune landscape of the tumor microenvironment, supporting the need for multi-sampling for precision medicine.

GENOME MEDICINE (2021)

Article Biochemistry & Molecular Biology

Modeling colorectal tumorigenesis using the organoids derived from conditionally immortalized mouse intestinal crypt cells (ciMICs)

Xiaoxing Wu et al.

Summary: In this study, a conditionally immortalized mouse intestinal crypt (ciMIC) cell line was established using a piggyBac transposon-based SV40 T antigen expression system. The ciMICs maintained long-term proliferative activity under a two-dimensional niche factor-containing culture condition, retained the biological characteristics of intestinal epithelial stem cells, and could form intestinal organoids in three-dimensional culture. Additionally, ciMICs overexpressing oncogenic beta-catenin and/or KRAS exhibited high proliferative activity and developed intestinal adenoma-like pathological features in vivo, suggesting their potential as a valuable tool cell line for studying genetic and/or epigenetic mechanisms of intestinal tumorigenesis.

GENES & DISEASES (2021)

Article Biochemical Research Methods

Microdissected cuboids for microfluidic drug testing of intact tissues

Lisa F. Horowitz et al.

Summary: Preclinical animal tests often fail to predict human drug effects accurately, leading to the need for functional drug testing platforms using human tissues. The authors developed a multi-well microfluidic platform for selective treatment of cuboidal-shaped tissues, showing potential for high throughput drug testing and automation in biological assays.

LAB ON A CHIP (2021)

Article Oncology

Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer

Ruoshi Shi et al.

CLINICAL CANCER RESEARCH (2020)

Article Cell Biology

A brief history of organoids

Claudia Corro et al.

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2020)

Article Cell & Tissue Engineering

Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids

Birgitta E. Michels et al.

CELL STEM CELL (2020)

Review Immunology

Organoid Models of Tumor Immunology

Kanako Yuki et al.

TRENDS IN IMMUNOLOGY (2020)

Article Biochemical Research Methods

Establishment of patient-derived cancer organoids for drug-screening applications

Else Driehuis et al.

NATURE PROTOCOLS (2020)

Article Medicine, Research & Experimental

PDX-derived organoids model in vivo drug response and secrete biomarkers

Ling Huang et al.

JCI INSIGHT (2020)

Review Medicine, Research & Experimental

Update of in vitro, in vivo and ex vivo fluoro-edenite effects on malignant mesothelioma: A systematic review

Veronica Filetti et al.

BIOMEDICAL REPORTS (2020)

Review Oncology

Biomarker-guided targeted and immunotherapies in malignant pleural mesothelioma

Haitang Yang et al.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)

Review Immunology

Organoids in immunological research

Yotam E. Bar-Ephraim et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

Is It Time to Start Transitioning From 2D to 3D Cell Culture?

Caleb Jensen et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Article Biochemical Research Methods

Flow-enhanced vascularization and maturation of kidney organoids in vitro

Kimberly A. Homan et al.

NATURE METHODS (2019)

Review Oncology

The current state of molecular testing in the treatment of patients with solid tumors, 2019

Wafik S. El-Deiry et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2019)

Article Multidisciplinary Sciences

Individual brain organoids reproducibly form cell diversity of the human cerebral cortex

Silvia Velasco et al.

NATURE (2019)

Article Multidisciplinary Sciences

CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes

Haruna Takeda et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Multidisciplinary Sciences

Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening

Minsuh Kim et al.

NATURE COMMUNICATIONS (2019)

Review Oncology

Modelling cancer in microfluidic human organs-on-chips

Alexandra Sontheimer-Phelps et al.

NATURE REVIEWS CANCER (2019)

Article Biochemistry & Molecular Biology

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity

Norman Sachs et al.

Article Biochemistry & Molecular Biology

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer

Suk Hyung Lee et al.

Editorial Material Cell & Tissue Engineering

Organoid Models of Cancer Explode with Possibilities

Senthil K. Muthuswamy

CELL STEM CELL (2018)

Review Biochemistry & Molecular Biology

Heterogeneity in Malignant Pleural Mesothelioma

Kathrin Oehl et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemistry & Molecular Biology

Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture

Tatsuya Usui et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Oncology

Novel therapies for malignant pleural mesothelioma

Arnaud Scherpereel et al.

LANCET ONCOLOGY (2018)

Article Neurosciences

Generation of human vascularized brain organoids

Missy T. Pham et al.

NEUROREPORT (2018)

Article Multidisciplinary Sciences

Patient-derived organoids model treatment response of metastatic gastrointestinal cancers

Georgios Vlachogiannis et al.

SCIENCE (2018)

Article Multidisciplinary Sciences

In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening

Andrea R. Mazzocchi et al.

SCIENTIFIC REPORTS (2018)

Review Oncology

Organoid technology and applications in cancer research

Hanxiao Xu et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Editorial Material Multidisciplinary Sciences

Organoids reveal cancer dynamics

Calvin J. Kuo et al.

NATURE (2018)

Article Multidisciplinary Sciences

Intra-tumour diversification in colorectal cancer at the single-cell level

Sophie F. Roerink et al.

NATURE (2018)

Article Biochemistry & Molecular Biology

Organoid Modeling of the Tumor Immune Microenvironment

James T. Neal et al.

Article Oncology

Integrative Molecular Characterization of Malignant Pleural Mesothelioma

Jutija Hmeljaki et al.

CANCER DISCOVERY (2018)

Review Oncology

Organoids in cancer research

Jarno Drost et al.

NATURE REVIEWS CANCER (2018)

Article Radiology, Nuclear Medicine & Medical Imaging

Functional Optical Imaging of Primary Human Tumor Organoids: Development of a Personalized Drug Screen

Alex J. Walsh et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Article Biochemistry & Molecular Biology

Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations

Julia Jabs et al.

MOLECULAR SYSTEMS BIOLOGY (2017)

Article Biotechnology & Applied Microbiology

In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis

Jatin Roper et al.

NATURE BIOTECHNOLOGY (2017)

Article Biochemistry & Molecular Biology

Human primary liver cancer-derived organoid cultures for disease modeling and drug screening

Laura Broutier et al.

NATURE MEDICINE (2017)

Review Biochemistry & Molecular Biology

Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery

Fleur Weeber et al.

CELL CHEMICAL BIOLOGY (2017)

Review Oncology

Novel insights into mesothelioma biology and implications for therapy

Timothy A. Yap et al.

NATURE REVIEWS CANCER (2017)

Review Pathology

Organoids as Models for Neoplastic Transformation

James T. Neal et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)

Article Biochemistry & Molecular Biology

Molecular profiling reveals primary mesothelioma cell lines recapitulate human disease

T. Chernova et al.

CELL DEATH AND DIFFERENTIATION (2016)

Review Oncology

Malignant Mesothelioma: Time to Translate?

Andrea Napolitano et al.

TRENDS IN CANCER (2016)

Article Biochemistry & Molecular Biology

Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients

Marc van de Wetering et al.

Article Oncology

Lung Cancer in the Era of Precision Medicine

Katerina Politi et al.

CLINICAL CANCER RESEARCH (2015)

Article Biochemistry & Molecular Biology

Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids

Mami Matano et al.

NATURE MEDICINE (2015)

Article Oncology

Drug repurposing in oncology-patient and health systems opportunities

Francesco Bertolini et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2015)

Review Pharmacology & Pharmacy

Matrigel: From discovery and ECM mimicry to assays and models for cancer research

Gabriel Benton et al.

ADVANCED DRUG DELIVERY REVIEWS (2014)

Article Biochemistry & Molecular Biology

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Dong Gao et al.

Article Biochemical Research Methods

A microfluidic platform for chemoresistive testing of multicellular pleural cancer spheroids

Janine Ruppen et al.

LAB ON A CHIP (2014)

Review Multidisciplinary Sciences

Organogenesis in a dish: Modeling development and disease using organoid technologies

Madeline A. Lancaster et al.

SCIENCE (2014)

Review Oncology

Molecular pathogenesis of malignant mesothelioma

Yoshitaka Sekido

CARCINOGENESIS (2013)

Article Pathology

Epithelial-mesenchymal transition in malignant mesothelioma

Ambrogio Fassina et al.

MODERN PATHOLOGY (2012)

Review Oncology

Advances in the biology of malignant pleural mesothelioma

P. A. Zucali et al.

CANCER TREATMENT REVIEWS (2011)

Article Biochemistry & Molecular Biology

mTOR Mediates Survival Signals in Malignant Mesothelioma Grown as Tumor Fragment Spheroids

Shannon M. Wilson et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)

Article Oncology

A conditional mouse model for malignant mesothelioma

Johan Jongsma et al.

CANCER CELL (2008)

Article Multidisciplinary Sciences

Induced pluripotent stem cell lines derived from human somatic cells

Junying Yu et al.

SCIENCE (2007)

Article Biochemistry & Molecular Biology

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

Kazutoshi Takahashi et al.

Article Biochemistry & Molecular Biology

A novel in vitro model of human mesothelioma for studying tumor biology and apoptotic resistance

KL Kim et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2005)

Article Oncology

A mouse model recapitulating molecular features of human mesothelioma

DA Altomare et al.

CANCER RESEARCH (2005)